Section Arrow
NVAX.NASDAQ
- Novavax
Quotes are at least 15-min delayed:2026/04/15 09:30 EDT
Regular Hours
Last
 --
-- (--)
Day High 
-- 
Prev. Close
8.39 
1-M High
10.9387 
Volume 
-- 
Bid
8.37
Ask
8.45
Day Low
-- 
Open
-- 
1-M Low
7.565 
Market Cap 
1.37B 
Currency 美元 
P/E 3.25 
%Yield -- 
10-SMA 8.14 
20-SMA 8.76 
50-SMA 9.16 
52-W High 11.97 
52-W Low 5.8 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
2.58/-0.13
Enterprise Value
1.61B
Balance Sheet
Book Value Per Share
-0.78
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.12B
Operating Revenue Per Share
5.98
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ZYMEZymeworks-------- 
ZVRAZevra Therapeutics------7.25PE
ZURAZura Bio Limited-------- 
ZNTLZentalis Pharmaceuticals-------- 
ZLABZai Lab Limited-------- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly ownedSwedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Thecompany manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.